在接受直接口服抗凝剂 (DOACs) 的患者中评估血栓风险的新兴生物标志物
Ashmi Sabana M1, Alwin Simon M1
1Department of Pharmacy Practice, JKKN College of Pharmacy, Namakkal, India.
Cardiovascular & hematological agents in medicinal chemistry
|December 17, 2024
概括
在服用直接口服抗凝剂 (DOACs) 的患者中评估血栓形成风险至关重要. 新兴的生物标志物和遗传因素显示出个性化风险评估的前景,平衡血栓形成和出血风险.
科学领域:
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
背景情况:
- 直接口服抗凝剂 (DOAC) 在血栓性疾病中比维生素K对抗剂 (VKA) 有优势.
- 评估在DOAC患者中复发性血栓形成风险至关重要,因为当前的风险得分有局限性.
- 需要个性化风险评估来平衡血栓形成和出血风险.
研究的目的:
- 审查目前在预测静脉血栓栓塞 (VTE) 风险的局限性,在DOAC治疗的患者.
- 探索新兴的生物标志物和遗传因素,以改善血栓风险评估.
- 讨论针对个性化抗凝药的临床,遗传和生物标记数据的整合.
主要方法:
- 对DOACs,VTE风险和生物标志物研究的文献综述.
- 分析遗传因素 (例如VKORC1,CYP2C9变体) 和它们在抗凝血中的作用.
- 评估循环生物标志物,如VIII因子和可溶性P-选择素.
主要成果:
- 目前的风险评分不足以预测特定DOAC群体的VTE.
- 升高的VIII因子水平与癌症相关的血栓形成症 (CAT) 患者的静脉瘤复发风险相关.
- 可溶性P-选择素显示出作为VTE复发标志物的潜力,改善了像维也纳CATS这样的风险模型.
结论:
- 整合临床因素,遗传学和生物标志物可以优化DOAC用户的血栓风险评估.
- 需要进一步的研究和更大的研究来验证生物标志物和标准化测试.
- 个性化抗凝策略对于有效管理血栓形成和出血风险至关重要.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
608
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
608
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
467
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
467
01:24Disorders of Hemostasis
699
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
699
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
100
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
100